Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadaaki Yamada

Showing results (11-20 of 228) with videos related to

Pageof 23
Sort By:
Journal of Pain Research|April 14, 2020
A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid TherapyLynn R Webster, Martin E Hale, Tadaaki Yamada, et al.
The Lancet. Gastroenterology & Hepatology|June 4, 2017
Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trialsMartin Hale, James Wild, Jyotsna Reddy, et al.
Respirology Case Reports|July 23, 2020
Advanced G-CSF-producing non-small cell lung cancer-not otherwise specified, with favourable response to pembrolizumab monotherapyYohei Matsui, Tadaaki Yamada, Naoko Masuzawa, et al.
Anticancer Research|September 21, 2012
Prognostic value of acquired resistance-related molecules in Japanese patients with NSCLC treated with an EGFR-TKIHidetaka Uramoto, Tadaaki Yamada, Seiji Yano, et al.
Respirology Case Reports|October 3, 2018
Effective combined therapy with ramucirumab for advanced pulmonary pleomorphic carcinomaNaoya Nishioka, Yoshiko Kaneko, Tadaaki Yamada, et al.
Cancer Genomics & Proteomics|February 29, 2024
POLD1 Is Required for Cell Cycle Progression by Overcoming DNA Damage in Malignant Pleural MesotheliomaDaiki Shimizu, Miku Ishibashi, Tadaaki Yamada, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 18, 2011
Hepatocyte growth factor induces resistance to anti-epidermal growth factor receptor antibody in lung cancerTadaaki Yamada, Shinji Takeuchi, Kenji Kita, et al.
Pulmonary Pharmacology & Therapeutics|October 19, 2006
Thioredoxin-1 protects against hyperoxia-induced apoptosis in cells of the alveolar wallsTadaaki Yamada, Yoshinobu Iwasaki, Kazuhiro Nagata, et al.
Biosensors & Bioelectronics|February 19, 2021
Plasma membrane anchored nanosensor for quantifying endogenous production of H<sub>2</sub>O<sub>2</sub> in living cellsShigekuni Hosogi, Yoshinori Marunaka, Eishi Ashihara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2011
[PI3K inhibitor]Seiji Yano, Shinji Takeuchi, Tadaaki Yamada, et al.
Pageof 23

Showing results (11-20 of 228) with videos related to

Sort By:
Pageof 23
Journal of Pain Research|April 14, 2020
A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid TherapyLynn R Webster, Martin E Hale, Tadaaki Yamada, et al.
The Lancet. Gastroenterology & Hepatology|June 4, 2017
Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trialsMartin Hale, James Wild, Jyotsna Reddy, et al.
Respirology Case Reports|July 23, 2020
Advanced G-CSF-producing non-small cell lung cancer-not otherwise specified, with favourable response to pembrolizumab monotherapyYohei Matsui, Tadaaki Yamada, Naoko Masuzawa, et al.
Anticancer Research|September 21, 2012
Prognostic value of acquired resistance-related molecules in Japanese patients with NSCLC treated with an EGFR-TKIHidetaka Uramoto, Tadaaki Yamada, Seiji Yano, et al.
Respirology Case Reports|October 3, 2018
Effective combined therapy with ramucirumab for advanced pulmonary pleomorphic carcinomaNaoya Nishioka, Yoshiko Kaneko, Tadaaki Yamada, et al.
Cancer Genomics & Proteomics|February 29, 2024
POLD1 Is Required for Cell Cycle Progression by Overcoming DNA Damage in Malignant Pleural MesotheliomaDaiki Shimizu, Miku Ishibashi, Tadaaki Yamada, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 18, 2011
Hepatocyte growth factor induces resistance to anti-epidermal growth factor receptor antibody in lung cancerTadaaki Yamada, Shinji Takeuchi, Kenji Kita, et al.
Pulmonary Pharmacology & Therapeutics|October 19, 2006
Thioredoxin-1 protects against hyperoxia-induced apoptosis in cells of the alveolar wallsTadaaki Yamada, Yoshinobu Iwasaki, Kazuhiro Nagata, et al.
Biosensors & Bioelectronics|February 19, 2021
Plasma membrane anchored nanosensor for quantifying endogenous production of H<sub>2</sub>O<sub>2</sub> in living cellsShigekuni Hosogi, Yoshinori Marunaka, Eishi Ashihara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2011
[PI3K inhibitor]Seiji Yano, Shinji Takeuchi, Tadaaki Yamada, et al.
Pageof 23